Antibody to human α-fetoprotein inhibits cell growth of human hepatocellular carcinoma cells by resuscitating the PTEN molecule: in vitro experiments

International Journal of Oncology
Kiyoshi OhkawaTomokazu Matsuura

Abstract

It has been proposed that α-fetoprotein (AFP) is a new member of the intracellular signaling molecule family of the phosphoinositide 3-kinase (PI3K)/AKT signaling pathway via interaction with the phosphatase and tensin homolog (PTEN). In this study, the effects of anti-human AFP antibody on the functions of PTEN were examined using an AFP-producing human hepatoma cell line. The antibody caused significant inhibition of cell growth, compared to a normal IgG control, with the accumulation of intracellular immune complexes followed by significant reduction of cytosolic functional AFP. Decrease in the amount of AKT phosphorylated on serine (S) 473 indicated that PI3K/AKT signaling was suppressed in the cells. S380-phosphorylated PTEN increased markedly by the second day after antibody treatment, with slight but significant increase in the PTEN protein level. Since phosphorylation at S380 is critical for PTEN stability, the increase in S380-phosphorylated PTEN indicated maintenance of the number of PTEN molecules and the related potential to control PI3K/AKT signaling. p53 protein (P53) significantly, but slightly increased during antibody treatment, because PTEN expression increased the stability and function of P53 via both molecu...Continue Reading

References

Jun 1, 1975·Journal of the National Cancer Institute·G J MizejewskiR P Allen
Nov 1, 1978·Clinical Immunology and Immunopathology·G J Mizejewski, R P Allen
Nov 27, 1992·Cell·T R HuppD P Lane
Feb 15, 1974·International Journal of Cancer. Journal International Du Cancer·Y TsukadaH Hirai
Jul 5, 1974·Nature·G J Mizejewski, R P Allen
May 15, 1980·International Journal of Cancer. Journal International Du Cancer·H T WepsicH Hirai
Jan 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·Y TsukadaM Sela
Dec 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·Y TsukadaH Hirai
Apr 15, 1984·International Journal of Cancer. Journal International Du Cancer·K OhkawaH Hirai
Mar 15, 1980·Cancer·E E KimD M Goldenberg
May 15, 1997·Nature·Y HauptM Oren
Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·M M GeorgescuH Hanafusa
Jun 24, 2000·Molecular and Cellular Biology·F VazquezW R Sellers
Nov 23, 2000·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·D HaidopoulosG F Androulakis
Mar 21, 2001·FEBS Letters·E HajduchH S Hundal
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·L D Mayo, D B Donner
Nov 21, 2001·Nature Cell Biology·B P ZhouM C Hung
Jun 5, 2002·World Journal of Gastroenterology : WJG·Meng-Sen LiGang Li
Jun 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Diana BirleTomas Mustelin
Dec 31, 2002·Expert Review of Anticancer Therapy·Gerald J Mizejewski
Mar 5, 2003·Journal of Cell Science·Bradley W Doble, James R Woodgett
Sep 10, 2004·The Journal of Biological Chemistry·Fumiaki OkaharaTomohiko Maehama
Aug 19, 2006·Molecular Cell·Andrew G LiXuan Liu
Apr 21, 2007·The Biochemical Journal·Helene MaccarioNick R Leslie
Nov 23, 2007·Journal of Cell Science·Tanja Tamguney, David Stokoe

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.